IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.822
NA - Nord America 2.885
AS - Asia 1.984
SA - Sud America 243
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 63
OC - Oceania 5
Totale 11.115
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 3.763
US - Stati Uniti d'America 2.728
RU - Federazione Russa 807
SG - Singapore 739
IT - Italia 516
CN - Cina 378
HK - Hong Kong 327
VN - Vietnam 214
BR - Brasile 183
DE - Germania 146
GB - Regno Unito 118
FR - Francia 116
IE - Irlanda 111
CA - Canada 89
BD - Bangladesh 75
ID - Indonesia 57
SE - Svezia 41
IN - India 36
ES - Italia 33
MX - Messico 32
UA - Ucraina 29
BJ - Benin 27
FI - Finlandia 27
KR - Corea 26
PL - Polonia 22
AR - Argentina 20
CZ - Repubblica Ceca 17
IQ - Iraq 17
JP - Giappone 17
AT - Austria 15
ZA - Sudafrica 15
TR - Turchia 14
CH - Svizzera 13
PK - Pakistan 12
JM - Giamaica 11
JO - Giordania 11
VE - Venezuela 10
BE - Belgio 9
EC - Ecuador 9
LT - Lituania 8
PH - Filippine 7
CO - Colombia 6
CR - Costa Rica 6
EE - Estonia 6
MD - Moldavia 6
AU - Australia 5
DZ - Algeria 5
IL - Israele 5
MY - Malesia 5
NI - Nicaragua 5
RO - Romania 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AZ - Azerbaigian 4
CL - Cile 4
GR - Grecia 4
IR - Iran 4
MA - Marocco 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
GT - Guatemala 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
CY - Cipro 2
EG - Egitto 2
HR - Croazia 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 11.003
Salva come PNG Salva come JPEG
Città #
Amsterdam 3.745
San Jose 337
Council Bluffs 326
Hong Kong 326
Singapore 304
Ashburn 242
Beijing 126
Dublin 111
Phoenix 102
New York 99
Los Angeles 96
Columbus 92
St Louis 88
Lauterbourg 74
Turin 74
Moscow 68
Milan 65
Hanoi 57
Ho Chi Minh City 51
Santa Clara 49
Jakarta 44
Chicago 42
Dallas 41
Munich 41
Orem 38
Vercelli 34
Denver 33
Novara 33
Buffalo 31
Jacksonville 31
São Paulo 28
Cotonou 27
Frankfurt am Main 27
Boardman 26
Atlanta 25
San Francisco 25
Brooklyn 24
Manchester 23
London 22
Montreal 22
Warsaw 21
Toronto 19
Genoa 18
Seoul 18
Chennai 17
Falkenstein 17
Mexico City 17
Brno 16
Chandler 16
Houston 16
Nuremberg 16
Rome 16
Tokyo 16
Boston 14
Dearborn 13
Stockholm 13
Helsinki 12
Poplar 12
Schaumburg 12
Amman 11
Las Vegas 10
Ankara 9
North Bergen 9
Omaha 9
Philadelphia 9
Bologna 8
Brasília 8
Da Nang 8
Naples 8
Rio de Janeiro 8
Shanghai 8
Vienna 8
Baghdad 7
Biên Hòa 7
Haiphong 7
Johannesburg 7
Kingston 7
Princeton 7
Vancouver 7
Wilmington 7
Alessandria 6
Borgomanero 6
Guangzhou 6
Guayaquil 6
Hillsboro 6
Lawrence 6
Newark 6
Olathe 6
Tianjin 6
Tornaco 6
Belo Horizonte 5
Bexley 5
Brandon 5
Brussels 5
Charlotte 5
Guarulhos 5
Madrid 5
Managua 5
Miami 5
Mumbai 5
Totale 7.627
Salva come PNG Salva come JPEG
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.993
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.990
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 206
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 185
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 160
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 157
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 149
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 146
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 143
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 140
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 138
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment 137
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 134
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 132
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 128
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 113
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 112
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 110
The Extracellular NADome Modulates Immune Responses 110
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 105
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 101
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 99
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 97
NAMPT AND AUTOANTIBODIES: A POSSIBLE ASSOCIATION FOR AUTOIMMUNE DIAGNOSTICS? 94
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 94
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 94
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 94
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 93
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 89
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 89
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 88
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 88
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 86
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 84
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 81
NAMPT: A critical driver and therapeutic target for cancer 81
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 80
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 80
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 80
Effects of Ether Perfluoro Carboxyl Acids (PFECAs) on Innate Immunity in Earthworms (Eisenia fetida) 79
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 78
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 78
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 77
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 76
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 76
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 75
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 75
Editorial: Metabolic reprogramming in cancer 74
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 72
Translational reprogramming in BRAF inhibitors resistant melanoma: the impact of NAMPT/NAD metabolism in mTOR-dependent regulation of protein synthesis. 71
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 71
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 71
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 69
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets" 67
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 66
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 66
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 66
CD38 in chronic lymphocytic leukemia: from bench to bedside? 64
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 63
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 62
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 60
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 58
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 58
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 58
PRO-INFLAMMATORY ROLE OF EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN CYSTIC FIBROSIS 57
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 56
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 56
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 56
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 55
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 54
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 54
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma 53
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 51
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 51
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 50
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells 49
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 49
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 49
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 47
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 45
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 45
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 44
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 41
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 40
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 40
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 38
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 38
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 34
Secondary amide derivatives of Fe(III)-CDTA: Impact of ligand substitution on relaxivity, stability, and kinetic inertness 30
null 23
Totale 11.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/20251.346 46 5 119 34 92 54 177 91 456 53 56 163
2025/20267.742 167 153 171 403 416 340 508 597 4.035 418 280 254
2026/20271.299 215 444 352 288 0 0 0 0 0 0 0 0
Totale 11.115